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The aim of this paper is to determine the profile of acute alcohol poisoning and to estimate the risk of 
potentially adverse drug interactions (ADIs) in patients intoxicated by alcohol when attended in emergency 
care at hospital. A descriptive serial cross-sectional study was performed with 4,271 individuals intoxicated 
by alcohol, from January 2009 to July 2011. Possible correlations were measured by Pearson’s chi-square 
test. The data show high consumption in the population, especially in males between 25 and 59 years. 
The main circumstances for poisoning were alcohol misuse (96.3%). After treatment complete recovery 
from the signs or symptoms of the poisoning was observed in 96.88% cases; and death in 0.70%. The 
demonstration of potential risk for ADIs in medical care included 300 medical records which contained a 
history of acute alcohol poisoning. Possible drug-drug interactions (44.2%) and drug-alcohol interactions 
(55.8%) were demonstrated in 60.60% of analyzed medical records. Among these cases, 3%, 92.4% 
and 4.6% were classified as mild, moderate and severe, respectively. The measurement of ADIs aims to 
prevent clinical complications in medical care for alcohol misuse disorders.
Uniterms: Alcoholic intoxication. Emergency Medical Services. Risk Management. Medicines/adverse 
interactions/risk control. Medicines/alcohol interactions/risk control.
O objetivo deste trabalho foi definir o perfil de intoxicação alcoólica aguda e estimar o risco de interações 
medicamentosas adversas (IMAs) potenciais em pacientes com intoxicação alcoólica atendidos na 
emergência hospitalar. Um estudo descritivo, serial, de corte transversal foi realizado com 4.271 
indivíduos com intoxicação alcoólica, de janeiro 2009 a julho 2011. Correlações foram medidas pelo 
teste qui-quadrado. Os dados mostram alto consumo na população estudada, especialmente em homens 
de 25 a 59 anos. A principal circunstância de intoxicação foi o abuso (96,3%). Após tratamento, cura 
foi observada em 96,88% dos casos e morte em 0,7%. O risco de IMAs potenciais no atendimento 
médico incluiu 300 prontuários médicos com histórico de intoxicação alcoólica aguda. Possíveis 
interações medicamentosas (44,2%) e interações fármaco-álcool (55,8%) foram observadas em 60,6% 
dos prontuários analisados. Entre elas, 3%, 92,4% e 4,6% foram classificadas como leve, moderada e 
grave, respectivamente. A medição das IMAs visa a prevenir complicações clínicas no atendimento dos 
agravos devido ao abuso de álcool.
Unitermos: Intoxicação alcoólica. Serviços Médicos de Emergência. Medicamentos/interações adversas/
controle de risco. Medicamentos/interação com álcool/controle de risco.
J. D. S. Andrade, C. E. Rocha, M. A. V. Maciel, D. C. A. S. Santana, F. J. M. Santana134
INTRODUCTION
In Brazil, poisoning cases are continuously reported 
to the State Poisoning Information Centers (CIATOX), 
members of the National Poisoning Information System 
(SINITOX).
The center is a specialized unit that provides 
information, guidance and advice on the diagnosis, 
prognosis and management of the poisoned patient, as well 
as promoting the prevention of poisoning for the whole 
medical and non-medical community. According to the 
CIATOX of the state of Sergipe (SE), in the Northeast 
of Brazil, alcohol played its role in 39.30% of Brazil’s 
poisoning cases by drug misuse, as reported in 2011 
(SINITOX, 2011).
Acute poisoning is the common cause for entry 
into hospital emergency department (ED) admissions 
worldwide. The World Health Organization (WHO) 
estimates that 50% of alcohol-related injuries are 
attributable to acute poisonings and the other 50% to 
chronic alcohol consumption (Ye, Cherpitel, 2009).
These intoxications exclude alcoholics, or those 
consumers at risk of harm, and include those who 
have suffered some health damage by periodic heavy 
(“binge”) alcohol drinking (Roizen, 2009). Excessive 
alcohol consumption is a common social practice, 
often resulting in a set of physical and mental disorders 
(loss of inhibition, cognitive impairment, decreased 
attention span, a worsening of judgment, impaired 
motor coordination, irritability, etc.). These events 
cause unwanted consequences not only to those who 
are intoxicated but also to society, in all countries. Some 
studies have come to suggest that sporadic binge drinking 
can cause more social and health damage than continuous 
use (Naimi et al., 2003; Segatto et al., 2007). 
The hazardous alcohol-injury association caused by 
episodic, acute alcohol consumption – from the intentions 
to commit violence and attempt suicide to unintentional 
consequences (isolated accidents) - is of growing concern 
to Health Agencies around the world (Naimi et al., 2003).
Regardless of how these exposures of the problem 
occur, through acute or chronic intake, medical attention 
for alcohol-related deaths (cirrhosis, some cancers, 
cerebral stroke, mental disorders, loss of consciousness, 
respiratory depression, apnea and coma) is highly costly 
and unyielding. In severe cases, drinking alcohol may 
cause permanent physiological disorders or even death 
(Schuckit, 2011).
Adverse drug events (ADEs) are common and 
expensive for medicine. In ED, ADEs are an important 
and recognized cause of medical errors related to drugs 
(Vonbach et al., 2008; Bates et al., 1997).
Among the ADE risk factors, adverse drug 
interactions (ADIs) resulting from inappropriate 
prescribing of drugs in emergency rooms may endanger 
hospitalized patients’ health. Therefore, these interactions 
deserve special attention (Heininger-Rothbucher et al., 
2001). Inducing the potential risk of ADIs, co-prescription 
of multiple drugs in order to improve the effectiveness 
of the treatment regime, to reduce toxicity, or to treat 
coexisting diseases, is a common strategy in hospitals, 
including the emergency department (Bosch et al., 2012).
Historically, alcohol use is often associated with 
several legal or illegal drugs of abuse (commonly by 
teens) and can have serious consequences, such as those 
resulting from adverse drug-alcohol interactions (Gudin 
et al., 2013). Research on ADIs with drugs of abuse in 
emergency departments has not become routine. However, 
many adverse effects and deaths that are attributed to drug 
abuse toxicity alone are, often, actually the result of drug 
interactions.
This study aims to describe the acute alcohol 
poisoning patient’s profile, attended in ED and reported 
to CIATOX-SE; as well as to estimate the prevalence and 
gravity of ADIs in emergency hospital-medical care of 
these patients.
METHOD
This is a descriptive and retrospective serial cross-
sectional regional study conducted for a population of 
4,271 patients intoxicated by alcohol, from January 2009 
to July 2011.
The data for this population was collected from the 
CIATOX-SE database. This unit is located at the main 
emergency hospital of Sergipe (HUSE), in the state capital 
(Aracaju), and it is the state’s benchmark in emergency 
services for poisoning.
The sample included all patients diagnosed as F10.0 
according to the International Classification of Diseases 
and Related Health Problems, 10th Revision (ICD-10). 
F10.0 refers to mental and behavioral disorders caused by 
the use of alcohol - acute intoxication (WHO, 2010). These 
patients were attended in the EDs of the main hospitals 
located in Aracaju’s metropolitan area; and their medical 
records information was reported to CIATOX-SE.
The independent variables were: gender, age, 
geographical area of residence, origin of place, 
circumstances of poisoning, type of exposure, length of 
hospital stay and medical care outcome.
The drugs used in emergency hospital-medical care, 
length of hospital stay information, as well as the patient’s 
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legal and/or illegal drug abuse associated with alcohol 
consumption, were collected from the medical records of 
a representative sample of patients intoxicated by alcohol. 
These records were supplied by the Hospital Statistics 
Department and Medical Archive (SAME/HUSE) and 
were used to analyze the potential risk of ADIs occurring 
in the acute alcohol poisoning cases attended in ED. 
The representat ive sample was calculated 
considering the prevalence of patients intoxicated by 
alcohol over the total of individuals intoxicated by drug 
abuse and reported to the CIATOX-SE during the study 
period.
A 5% margin of error (95% confidence interval) 
was adopted. The sample size was calculated by simple 
random sampling and 300 medical records were selected 
and analyzed for the potential risk of ADIs.
Medical records that were erased, illegible, 
inaccessible, and/or belonging to transferred patients 
(who during the emergency hospital-medical care were 
transferred to another hospital) were excluded from the 
sample.
Adverse drug-drug and drug-alcohol interactions 
were assessed by computer software. The level of 
significance for interaction (severe, moderate and 
mild) was classified according to Drug.com® database 
- a computerized drug-drug interaction (DDI) screening 
program. Drug.com® compiles medical information from: 
Wolters Kluwer HealthTM, the American Society of Health-
System PharmacistsTM, Cerner MultumTM and Thomson 
Reuters MicromedexTM databases (Drug Interactions 
Checker: <http://www.drugs.com/drug_interactions.
html).
All statistical analyses were performed using the Epi 
Info program version 3.3 for Windows. Data were showed 
as mean (M), standard deviation (SD), absolute frequency 
(n) and relative frequency (%). The relationship between 
poisoning circumstances and age was established using 
the Pearson chi-square test (x2). P values less than 0.05 
are reported as statistically significant.
This study was approved by both the Ethics 
Committee of the Federal University of Sergipe (CEP 
no 370/2011 and CAAE no 0332.0.107.000-11) and the 
Continuing Education Center of the HUSE hospital 
complex.
RESULTS AND DISCUSSION
During the study period, 15,818 acute cases of 
intoxication by drug abuse occurred. Alcohol had the 
highest prevalence (27.30%) among all toxic agents 
involved. This high prevalence was expected since in 
accordance with the United Nations Office on Drugs and 
Crime (UNODC), alcohol is the most widely consumed 
licit psychoactive substance in the world (UNODC, 2013). 
TABLE I - Distribution of independent variables: gender, age, 
geographical area of residence, place of origin, circumstances 
of poisoning, type of exposure and medical care outcome in 
4,271 cases of acute alcohol poisoning. Sergipe, January 2009 
to July 2011
Variables AFa (n) RFb (%)
Gender
Men 3,793 88.81
Women 478 11.19
Total 4,271 00
Age group (yrs.)
01 ┤11 5 0.12
12 ┤17 89 2.08
18 ┤24 530 12.41
25 ┤34 1,038 24.31
35 ┤44 1,134 26.56
45 ┤59 1,116 26.12
60 + 216 5.05
U* 143 3.35
Total 4,271 100
Place of Origin
Capital city 2,708 63.41
Neighboring cities 1,563 36.59
Total 4,271 100
Geographical Area
Urban 4,090 95.78
Rural 173 4.06
U* 7 0.16
Total 4,271 100
Circumstance
Abuse (misuse) 4,113 96.30
Accidental 101 2.36
U* 57 1.34
Total 4,271 100
Medical care outcome
Cured 4,138 96.88
Death 30 0.70
Not specified 103 2.42
Total 4,271 100
AFa, Absolute Frequency (n); RFb, Relative Frequency (%). U, 
Uninformed.
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The acute alcohol poisoning profile is described in Table I.
The mean population was 37 years of age on 
average (±11); higher alcohol consumption was observed 
predominantly in the economically active population 
(ranging from 25 to 59 years of age).
Although not statistically significant, elderly 
individuals (age ≥ 60 years old) accounted for 5.05% 
of acute alcohol poisoning cases. Nonetheless, this is a 
worrisome result because these individuals usually have 
a longer hospital stay due to severe injuries directly and/
or indirectly associated with alcohol. Furthermore, studies 
have shown that the need for co-administration of five or 
more drugs increases the potential risk of ADI in elderly 
patients intoxicated by alcohol (Mallet, Spinewine, Huang, 
2007; Fulton, Allen, 2005).
The sample size included 3,793 men and 478 
women, in an 8:1 ratio. This great difference can be 
explained considering both physiological processes and 
socio-cultural aspects.
Studies have demonstrated a higher alcohol blood 
concentration in women than in men after drinking the 
same amount of alcohol. Women consuming a smaller 
amount of alcohol than men will have similar psychoactive 
reactions. The differences in the effects on gender can be 
explained when considering alcohol’s distribution in the 
human body – in terms of metabolism - in the bodies of 
men and women. Compared to men, women usually have 
smaller volumes of water in their body when alcohol is 
distributed. Besides, they have a less efficient first passive 
recovery in their metabolism when alcohol is involved, 
leading to greater absorption of alcohol directly into the 
bloodstream (Dettling et al., 2008; Nanchahal, Ashton, 
Wood, 2000; Wilsnack et al., 2000).
Some authors also suggest that gender difference 
in alcohol consumption depends on the type of alcoholic 
beverage (wine, beer, and others) most consumed in each 
group. Furthermore, it depends on how each society faces 
the role of drinking for men and women (Miller, Plant, 
Plant, 2005). The prevalence of beer among the Brazilian 
population partly explains the higher incidence of acute 
alcohol poisoning in the young men observed in our 
study. Needless to say, women have an important moral 
and conservative role in family life, and in social life, in a 
good number of both developed and developing countries 
(Wilsnack et al., 2000).
Regarding the geographical area of residence 
and place of origin of the population under study, it is 
important to mention that the CIATOX-SE conducts active 
surveillance for intoxication cases only in hospitals located 
in the metropolitan area of Aracaju (i.e., Hospital São José, 
Hospital João Alves, Urgência Fernando Franco Hospital, 
Municipal Doutor Nestor Piva Hospital). Medical 
records of hospitals located in neighboring cities were 
not included. Under this condition, 63.41% of individuals 
resided in the state capital and 95.78% of individuals came 
from urban areas.
Despite the investigation being apparently restricted 
to urban areas and this possibly being a limitation of the 
study, we must consider that the land area of Sergipe 
State is the smallest of Brazil (21,915,116 km²) and that 
73.5% of the state’s inhabitants reside in urban areas. In 
addition, the metropolitan region of Aracaju (i.e., Aracaju, 
Barra dos Coqueiros, Nossa Senhora do Socorro, São 
Cristóvão) is the most populous area in the state with 
899,239 inhabitants (59.1% of the State’s inhabitants) 
(IBGE, 2014).
According to Table I, alcohol abuse accounted for 
almost all cases of acute drug-related poisoning. This 
circumstance is alarming since alcohol abuse is a major 
cause of road traffic complications and accidents, causing 
death and injury around the world, including in Brazil 
(Lukens et al., 2006). Episodes of alcohol abuse are also 
associated with higher risks of violent acts, including 
murder, sexual offenses and family violence (Rehm et al., 
1999). In England, a study showed that 42% of homicides 
between 1996 and 1999 involved the use of alcohol and 
illicit drug use by the perpetrator and/or victim (Shaw et 
al., 2006).
Our results show that in most cases, the length of 
the hospital stay was less than or equal to one day. Only 
6.70% patients remained hospitalized longer than one 
day. After medical care, healing was observed in 96.88% 
patients and 0.70% cases led to death. Although mortality 
was not numerically representative (only 30 cases) it must 
be viewed with concern since according to the Brazilian 
Health Agency, acute alcohol poisoning is considered a 
transient phenomenon with complete recovery, except 
when complications arise in hospital-medical care 
(American Psychiatric Association, 2006).
Table II describes the relationship between alcohol 
intoxication circumstances and age group.
Although not statistically significant, the misuse of 
alcohol in children and adolescents is an alert for easy and 
frequent access of young people to alcohol. This is also an 
alert for the Children and Adolescents Law in Brazilian 
(nº. 8069/9, art. 243), which prohibits the sale of alcoholic 
beverages to anyone under the age of 18 (Brazil, 2004). 
Besides determining the profile of alcohol poisoning 
(risk group), the last aim of this study was to estimate the 
potential risk of ADIs in emergency hospital-medical care 
of these groups to improve their clinical outcome.
In hospital-medical care there were prescribed 
Prevalence and risk of potentially adverse drug interactions in the treatment of acute alcohol poisoning 137
3.2 (± 2.16) drugs per patient and the potential risk of 
ADIs was observed in 182 (60.60%) prescriptions. 
In the pharmacotherapy of these individuals, about 
52 pharmaceutical of the applications prescribed 
demonstrated 77% of potential risk of ADIs.
In our study a total of 496 possible interactions 
were identified, of which 197 (44.22%) were classified 
as drug-drug interactions. Consequently, the population 
under study showed a high risk of potential for the therapy 
not being effective and/or clinical injuries in emergency 
hospital-medical care.
Because of the large number of co-administered 
drugs in hospital-medical care and the complexity of 
the drug interactions, some authors argue that a suitable 
characterization and control of every possible interaction 
for medical records is technically unfeasible. Therefore, 
the team dedicated to the well-being of the patient should 
focus its attention preferentially on those drugs which are 
used more frequently and show a higher potential risk 
of ADI, without disregarding other interactions (Hussar, 
2000).
Among the major drugs described in our study, 
diazepam, phenytoin, metoclopramide and promethazine 
were involved in over half of the potential risk of ADIs 
(64.55%). Metoclopramide, promethazine, and tramadol 
were involved in over 92% possible ADIs. Therefore, 
co-administration of these drugs requires a suitable risk 
management, and rigorous patient care, in order to avoid 
adverse reactions and/or therapeutic ineffectiveness.
Moderate risk of ADIs was observed in 92.40% of 
cases. This may induce clinical deterioration in patients 
and require additional medical care, or increase the length 
of the hospital stay. Severe risks of ADIs have proved to 
be less frequent (4.60%). These are very dangerous and 
may promote permanent adverse effects in patients. Thus, 
co-prescription of drugs involved in moderate or severe 
ADI cases should be vigorously avoided.
Mild ADI cases require patients’ monitoring, are 
less of a problem, and may induce some discomfort. This 
disturbance is onerous for hospital-medical care (Hussar, 
2000).
Although metoclopramide (an antiemetic drug) has 
been widely used in alcohol poisoning treatment, being the 
most frequently drug used (10.38%), it entails moderate 
and severe potential risk of ADIs (Table III).
Metoclopramide and scopolamine (antispasmodic 
drug) co-administration had the highest frequency of drug 
association observed by our study. This association of 
drugs showed moderate ADI gravity, reducing the action 
of metoclopramide and requiring dose adjustment for the 
effective treatment of patients (Hussar, 2000).
Other moderate and severe ADIs were described 
in Table III. Brief comments on the reasons for the 
administration of each drug in the pharmacotherapy of 
alcohol intoxication treatment are also included in Tables 
III and IV (Carlson et al., 2012). The few unwanted events 
resulting from these associations may have contributed to 
the cases of death previously described in our research. 
However, other studies must be done to confirm this 
hypothesis.
Besides the potential risk of ADIs between drugs 
used in alcohol poisoning treatment, alcohol itself can also 
be interacting with drugs prescribed to hospital-medical 
care of these patients. In our study there were identified 
299 (55.78%) drug-alcohol interactions.
These possible interactions may occur through 
TABLE II - Relationship between independent variables: circumstances of alcohol abuse and age. Sergipe. January 2009 to July 2011
Circumstance *Abuse **Accident
***U Total
Age group (yrs.) AFa RFb (%) AFa RFb(%)
01 ┤11 5 0.12 0 0 5
12 ┤17 85 2 3 0.07 1 89
18 ┤24 510 12 17 0.40 3 530
25 ┤34 1,009 23.62 16 0.37 13 1,038
35 ┤44 1,102 25.80 20 0.46 12 1,134
45 ┤59 1,092 25.56% 16 0.40 8 1,116
60 + 212 4.90% 2 0.04% 2 216
***U 98 2.30% 27 0.60% 18 143
Total 4,113 96.30% 101 2.34% 57 4,271
p > 0.05. AFa, Absolute Frequency (n); RFb, Relative Frequency (%). *Abuse, intentional drinking to excess, **Accidental, 
unintentional alcohol intoxication, ***U, Uninformed; **P, Pearson’s chi-square test (x2).
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different mechanisms and the clinical consequences are 
bilateral, i.e. alcohol can interfere with drug clinical events 
and vice versa (Fraser, 1997).
As observed in DDIs, metoclopramide was involved 
in the majority of drug-alcohol interactions (75% possible 
interactions) (Table IV). Another important association is 
alcohol and psychoactive drugs.
Similar to alcohol, many of these psychoactive drugs 
are central nervous system depressants. They increase the 
potential risk of moderate and severe pharmacodynamic 
interactions showing severe consequences for the 
physiological system (e.g., cumulative narcosis) (Vonbach 
et al., 2008).
Therefore, the use of psychoactive drugs for the 
management of anxiety, agitation and/or aggression, 
typical adverse events resulting from acute alcohol 
poisoning, requires a thorough control in pharmacotherapy 
and clinical monitoring of patients in emergency hospital-
medical care.
As shown in Table IV, the drugs used in hospital-
medical care of acute alcohol poisoning cases may directly 
or indirectly influence several alcohol pharmacokinetics 
parameters (e.g., absorption, bioavailability and 
biotransformation), including toxic alcohol metabolite 
formation (acetaldehyde).
On the other hand, alcohol may directly influence 
the hepatic metabolism of several drugs commonly used 
in acute alcohol poisoning emergency treatment.
TABLE III - Gravity, frequency, interactions, and possible adverse reactions of potential drug-drug interactions in acute alcohol 
intoxication for hospital emergencies. Sergipe, January 2009 to July 2011
Potential DDIsa DDIs and adverse events Gb AFc RFd (%)
Metoclopramide/
scopolamine
Scopolamine anticholinergic antiemetic drug. It is used to treat nausea, 
vomiting, and motion sickness for alcohol intoxication. In association, 
scopolamine reduces the effects of metoclopramide prokinetic in GITe.
*M 18 9.13
Metoclopramide/
diazepam
Diazepam is a sedative benzodiazepine drug. It decreases the 
progression of AWSf and the development of seizures. In association, 
metoclopramide-antiemetic drugs increase the depressive effects of 
diazepam on the CNSg and/or the respiratory system. 
*M 15 7.61
Diazepam/omeprazole Omeprazole is a proton-pump inhibitor drug showing a gastro protective 
effect on certain stomach and esophagus damage after alcohol abuse. In 
association, omeprazole increases diazepam pharmacological effects and 
serum levels through hepatic metabolic enzyme inhibition.
*M 10 5.07
Phenytoin/ranitidine Ranitidine is a histamine H2-receptor antagonist inhibiting excessive 
stomach acid production after alcohol drinking. In association, ranitidine 
increases the blood levels of phenytoin anticonvulsant drugs, leading to 
nausea, CNS dysfunction, in particular confusion, nystagmus, and ataxia; 
in depressed conscious states, seizures and coma, the latter occurring in 
more severe cases.
*M 9 4.57
Metoclopramide/
tramadol
Tramadol is an opioid painkiller. Seizures may increase after concomitant 
use of tramadol with metoclopramide, which reduces the seizure 
threshold. Furthermore, CNS- and/or respiratory-depressant effects of 
metoclopramide are enhanced after concomitant use of tramadol.
**S 4 2.03
Metoclopramide/
promethazine
Haloperidol and promethazine are neuroleptic drugs used for sedation 
of alcohol-related disruptive emergency patients - showing agitated, 
threatening, or violent behavior. The concomitant use of metoclopramide 
and neuroleptic drugs increases the incidence and severity of 
extrapyramidal reactions due to antidopaminergic additive effects.
**S 3 1.53
Metoclopramide/
haloperidol
**S 2 1.01
Other interactions 120 69.91
Total 197 100
aDDIs, Dug-Drug Interactions; bG, Gravity; cAF, Absolute Frequency (n); dRF, Relative Frequency (%); eGIT, Gastrointestinal Tract; 
fAWS, Alcohol Withdrawal Syndrome; gCNS, Central Nervous System. *M, Moderate; **S, Severe.
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While prolonged use of lower doses of alcohol 
(i.e., chronic intake) induce metabolism liver enzymes’ 
(CYP2E1) decreasing of plasma half-life (t1/2) with certain 
drugs, high doses of alcohol (e.g., binge drinking) compete 
for drug metabolism liver enzymes increasing plasma 
half-life (t1/2) for these drugs (Table IV) (Schuckit, 2011). 
In these cases, considering that some drugs 
prescribed for acute alcohol poisoning emergency hospital-
medical care are extremely toxic even at low doses (narrow 
therapeutic window drugs) or show high potential risk of 
ADI, any change in drug plasma concentration can lead 
to severe clinical complications in patients.
In  order  to  enhance pharmacotherapeut ic 
effectiveness and ensure safety in the emergency 
department, some suggestions could be: (i) dose 
adjustment, (ii) change in administration time, (iii) 
reduction in the number and/ or suspension of some drugs 
and, (iv) their replacement by others that have a mild risk 
of drug interactions with alcohol and other drugs used in 
pharmacotherapy.
Our research contributed to the identification of 
potentially dangerous alcohol intoxication scenarios 
and susceptible binge drinking groups, as well as to the 
clarification of chemical substances involved in alcoholic 
poisoning. 
Furthermore, this study has enabled us to describe 
the gravity of the frequency of ADIs in the emergency 
department. The potential risks described above show the 
lack of preparation in hospital teams in relation to the drug 
interaction issue, during routine hospital-medical care of 
patients intoxicated by alcohol. 
The description of the population profile alongside 
ADIs in the emergency room has contributed to health 
surveillance, as well as to evidence-based public health 
strategies, policy measures and effective interventions on 
a broader scale.
TABLE IV - Gravity, frequency, interaction mechanisms and possible adverse events of major potential drug-alcohol interactions 
in acute alcohol intoxication emergency hospital-medical care. Sergipe, January 2009 to July 2011
Potential DAIsa DAIs mechanism and adverse events Gb AFc RFd (%)
Alcohol/metoclopramide Metoclopramide increases alcohol eCNS depression compromising 
judgment, thinking, and psychomotor skills.
*M 75 25.08
Alcohol/diazepam Alcohol increases diazepam and scopolamine CNS depressant effects. *M 55 18.39
Alcohol/scopolamine *M 27 9.03
Alcohol/Ketoprofen The Ketoprofen anti-inflammatory drug, associated with alcohol, leads 
to gastrointestinal blood loss by inhibition of prostaglandins, decreasing 
mucosa gastrointestinal integrity.
*M 25 8.36
Alcohol/promethazine Promethazine is an antihistamine neuroleptic drug with strong sedative 
and weak antipsychotic effects. It also serves to reduce motion sickness 
and has an antiemetic effect, as well as anticholinergic properties. It 
is used in AWSf treatment. In association with alcohol, promethazine 
increases CNS depression leading to psychomotor disturbances, 
accelerating dystonic reactions in alcohol-intoxicated patients.
*M 23 7.69
Alcohol/phenytoin Alcohol increases the pharmacological effects and plasma levels of 
phenytoin by inhibiting the enzymatic metabolism of phenytoin.
*M 20 6.69
Alcohol/phenobarbital Phenobarbital is used to treat moderate and severe AWS in patients 
resistant to phenobarbital. In terms of DAI, acute alcohol consumption 
increases phenobarbital plasma levels by inhibition of hepatic enzymes 
and leading to impaired coordination, sedation and death.
**S 4 1.34
Alcohol/morphine Morphine is a powerful opioid painkiller drug used in management of 
severe pain in the Emergency Department. Co-administration of CNS 
depressant drugs significantly compromises the ability of judgment, 
thinking, and psychomotor skills. Furthermore, it leads to respiratory 
depression, sedation, hyper-tension and coma (in severe cases).
**S 2 0.67
Other interactions 68 22.74
Total 299 100
aDAIs, Dug-Alcohol Interactions; bG, Gravity; cAF, Absolute Frequency (n); dRF, Relative Frequency (%); eCNS, Central Nervous 
System; fAWS, Alcohol Withdrawal Syndrome. *M, Moderate; **S, Severe.
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Despite current public health policy discouraging 
binge drinking in the country, the data demonstrate a high 
consumption in the studied population. The measurement 
of possible drug interactions aims to contribute to the 
prevention of potential clinical complications in hospital-
medical care of alcohol misuse disorders. Thus, a thorough 
review on pharmacotherapy of these individuals must be 
introduced to ED clinical staff to reduce the prescription of 
drugs that have the potential to cause adverse interactions.
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